Skip to content

Insulet

US · PODD #1561 by market cap Listed 1970
133.17 -4.06 -2.96%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 134.90 -1.70%
After-hours 133.10 -0.05%
Overnight 136.44 -0.58%
170.62130.47133.172026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PODD?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -33.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 7.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 21.8x Better than 37%
Forward P/E 21.1x Better than 33%
Price / Sales 3.3x Better than 37%
P/E vs own 5-yr range 6th pctl Better than 94%
Growth A+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 27.5% Better than 89%
Net income CAGR (3Y) 277.3% Better than 99%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 71.6% Better than 84%
Operating margin 17.5% Better than 71%
Net margin 9.1% Better than 57%
Return on equity 18.1% Better than 75%
Return on invested capital 10.5% Better than 70%
Momentum D+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -10.1% Better than 50%
6-month return -14.0% Better than 34%
12-month return (ex latest month) -55.0% Better than 2%
Distance below 52-week high 61.1% Better than 10%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.8x Better than 71%
Debt to assets 29.8% Better than 42%
Interest coverage 6.7x Better than 64%
Free cash flow / net income 141.6% Better than 62%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 42.9% Better than 23%
Upside to average target 33.1% Better than 52%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -12.66%
1M -6.64%
3M -9.33%
6M -14.96%
YTD -53.15%
1Y -57.44%
3Y -26.53%
5Y -55.76%

Key statistics

Price & volume

Prev close
137.23
Open
134.97
Day range
132.38 - 140.47
Avg price
135.19
Volume
1.80M
Turnover
243.88M
Amplitude
5.90%
52-week range
126.40 - 342.13

Valuation

P/E
38.27
P/E (TTM)
21.76
P/B
5.85
EPS
3.48
Net profit
241.41M
Net assets
1.58B

Share structure

Market cap
9.24B
Float cap
7.95B
Shares out
69.37M
Float shares
59.67M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 3% of range
126.40 342.13

61.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.99M net over the window

Short interest

Shares short
5.33M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Insulet (PODD)?

Insulet last traded at 133.17. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Insulet's market cap?

About 9.24B.

What is the P/E ratio of Insulet?

The trailing twelve-month P/E is 21.76, below its own 5-year average of 1,814.54 — toward the bottom of its historical range (6.14% percentile). See the Valuation tab for the full history.

Does Insulet pay a dividend?

Insulet does not currently pay a regular dividend.

Is Insulet a buy according to analysts?

The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 177.23, which implies 33.1% upside from the current price. This is not investment advice.

What is Insulet's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Insulet a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:01:08 · For reference only, not investment advice and not tailored to your situation.

Insulet discussion 0 comments

Add a comment